Publications
Most Food Labeling Class Actions Remain Stayed While FDA Process Runs ‘Natural’ Course
October 23, 2017
Consumer class actions over the use of the term ‘‘natural’’ on product labels should be stayed in deference to the Food and Drug Administration’s ongoing consideration of regulatory action, Sidley lawyers Amy Lally and Amanda Farfel say. The large number of comments received by the FDA on the topic reflects the complexity of the issues and the need for expert guidance from the agency the authors say.
Capabilities
Suggested News & Insights
Delaware Chancery Ruling Addresses Public Benefit Corporation Directors’ Price-Maximization DutySeptember 22, 2026U.S. Department of Justice Announces Major Justice Manual Revisions on Sub-Regulatory Guidance and Dismissals of False Claims Act Qui TamsSeptember 21, 2026Sidley Secures US$640 Million Settlement for Genesis Healthcare Special Restructuring Committee Following High-Stakes Bankruptcy LitigationSeptember 18, 2026When the Meeting Minutes and the AI Transcript Don’t Match: Litigation Insights From Delaware ChancerySeptember 17, 2026Sidley Represents Vi-Jon in Chapter 11 CaseSeptember 14, 202622 Sidley Lawyers Named to 2027 Lawdragon 500 Leading Litigators in AmericaSeptember 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
